Search by Drug Name or NDC
NDC 66267-0071-20 Diclofenac Sodium 75 mg/1 Details
Diclofenac Sodium 75 mg/1
Diclofenac Sodium is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NuCare Pharmaceuticals,Inc.. The primary component is DICLOFENAC SODIUM.
Product Information
| NDC | 66267-0071 |
|---|---|
| Product ID | 66267-071_fc9ff1d6-3c1f-8a1e-e053-6294a90a7d5a |
| Associated GPIs | 66100007200630 |
| GCN Sequence Number | 008374 |
| GCN Sequence Number Description | diclofenac sodium TABLET DR 75 MG ORAL |
| HIC3 | S2B |
| HIC3 Description | NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS |
| GCN | 35852 |
| HICL Sequence Number | 003733 |
| HICL Sequence Number Description | DICLOFENAC SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Diclofenac Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Diclofenac Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | DICLOFENAC SODIUM |
| Labeler Name | NuCare Pharmaceuticals,Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077863 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66267-0071-20 (66267007120)
| NDC Package Code | 66267-071-20 |
|---|---|
| Billing NDC | 66267007120 |
| Package | 20 TABLET, DELAYED RELEASE in 1 BOTTLE (66267-071-20) |
| Marketing Start Date | 2018-01-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |